BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 19562718)

  • 1. Recurrent familial hypobetalipoproteinemia-induced nonalcoholic fatty liver disease after living donor liver transplantation.
    Harada N; Soejima Y; Taketomi A; Yoshizumi T; Uchiyama H; Ikegami T; Saibara T; Nishizaki T; Maehara Y
    Liver Transpl; 2009 Jul; 15(7):806-9. PubMed ID: 19562718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease.
    Yalamanchili K; Saadeh S; Klintmalm GB; Jennings LW; Davis GL
    Liver Transpl; 2010 Apr; 16(4):431-9. PubMed ID: 20373454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent disease following liver transplantation for nonalcoholic steatohepatitis cirrhosis.
    Malik SM; Devera ME; Fontes P; Shaikh O; Sasatomi E; Ahmad J
    Liver Transpl; 2009 Dec; 15(12):1843-51. PubMed ID: 19938117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic steatohepatitis in donors for living donor liver transplantation.
    Yamamoto K; Takada Y; Fujimoto Y; Haga H; Oike F; Kobayashi N; Tanaka K
    Transplantation; 2007 Feb; 83(3):257-62. PubMed ID: 17297396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of fatty liver in familial hypobetalipoproteinemia linked to chromosome 3p21.
    Yue P; Tanoli T; Wilhelm O; Patterson B; Yablonskiy D; Schonfeld G
    Metabolism; 2005 May; 54(5):682-8. PubMed ID: 15877300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Four novel mutations in APOB causing heterozygous and homozygous familial hypobetalipoproteinemia.
    Whitfield AJ; Marais AD; Robertson K; Barrett PH; van Bockxmeer FM; Burnett JR
    Hum Mutat; 2003 Aug; 22(2):178. PubMed ID: 12872264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric gallstone disease in familial hypobetalipoproteinemia.
    Lancellotti S; Zaffanello M; Di Leo E; Costa L; Lonardo A; Tarugi P
    J Hepatol; 2005 Jul; 43(1):188-91. PubMed ID: 15894400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Liver transplantation with a living donor: the first 3 cases in Rotterdam].
    Kazemier G; Metselaar HJ; de Man RA; Tran TC; Groenland TH; Tilanus HW
    Ned Tijdschr Geneeskd; 2008 Apr; 152(14):817-21. PubMed ID: 18491825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Living donor liver transplantation for Dorfman-Chanarin syndrome with 1 year follow-up: case report.
    Takeda K; Tanaka K; Kumamoto T; Morioka D; Endo I; Togo S; Shimada H
    Transplant Proc; 2010 Nov; 42(9):3858-61. PubMed ID: 21094870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allograft steatohepatitis in progressive familial intrahepatic cholestasis type 1 after living donor liver transplantation.
    Miyagawa-Hayashino A; Egawa H; Yorifuji T; Hasegawa M; Haga H; Tsuruyama T; Wen MC; Sumazaki R; Manabe T; Uemoto S
    Liver Transpl; 2009 Jun; 15(6):610-8. PubMed ID: 19479804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Auxiliary partial orthotopic living donor liver transplantation in a patient with alcoholic liver cirrhosis to overcome donor steatosis.
    Cho JY; Suh KS; Kwon CH; Yi NJ; Kim MA; Jang JJ; Minn KW; Lee KU
    Transpl Int; 2006 May; 19(5):424-9. PubMed ID: 16623878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative donor liver biopsy for adult living donor liver transplantation: risks and benefits.
    Nadalin S; Malagó M; Valentin-Gamazo C; Testa G; Baba HA; Liu C; Frühauf NR; Schaffer R; Gerken G; Frilling A; Broelsch CE
    Liver Transpl; 2005 Aug; 11(8):980-6. PubMed ID: 16035060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steatosis in donor and transplant liver biopsies.
    Crowley H; Lewis WD; Gordon F; Jenkins R; Khettry U
    Hum Pathol; 2000 Oct; 31(10):1209-13. PubMed ID: 11070113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of fatty liver disease and plasma lipoproteins in a kindred with familial hypobetalipoproteinemia due to a novel truncated form of apolipoprotein B (APO B-54.5).
    Tarugi P; Lonardo A; Ballarini G; Erspamer L; Tondelli E; Bertolini S; Calandra S
    J Hepatol; 2000 Sep; 33(3):361-70. PubMed ID: 11019990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypobetalipoproteinemia: genetics, biochemistry, and clinical spectrum.
    Tarugi P; Averna M
    Adv Clin Chem; 2011; 54():81-107. PubMed ID: 21874758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein B gene mutations and fatty liver in Japanese hypobetalipoproteinemia.
    Katsuda S; Kawashiri MA; Inazu A; Tada H; Tsuchida M; Kaneko Y; Nozue T; Nohara A; Okada T; Kobayashi J; Michishita I; Mabuchi H; Yamagishi M
    Clin Chim Acta; 2009 Jan; 399(1-2):64-8. PubMed ID: 18848826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute graft versus host disease following living donor liver transplantation: first Korean report.
    Cho EH; Suh KS; Yang SH; Lee HW; Cho JY; Cho YB; Yi NJ; Lee KU
    Hepatogastroenterology; 2007; 54(79):2120-2. PubMed ID: 18251173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late recurrence and rapid evolution of severe hepatopulmonary syndrome after liver transplantation.
    Krowka MJ; Wiseman GA; Steers JL; Wiesner RH
    Liver Transpl Surg; 1999 Sep; 5(5):451-3. PubMed ID: 10477847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Living donor liver transplantation: histological abnormalities found on liver biopsies of apparently healthy potential donors.
    Tran TT; Changsri C; Shackleton CR; Poordad FF; Nissen NN; Colquhoun S; Geller SA; Vierling JM; Martin P
    J Gastroenterol Hepatol; 2006 Feb; 21(2):381-3. PubMed ID: 16509862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nonalcoholic steatohepatitis in children].
    Cubelić S; Misak Z; Gasparov S; Kolacek S
    Lijec Vjesn; 2004; 126(7-8):197-200. PubMed ID: 15754789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.